Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2011 by Li Li, Next Capital (嘉程资本) is an early-stage investment firm based in China. The firm specializes in angel investments and currently manages a portfolio of 15 companies. It focuses on technology-driven investments across various sectors, including consumer goods, healthcare, and fintech.
Next Capital invests in early-stage companies during the angel round, particularly those that disrupt existing markets or create new value chains. The firm targets sectors such as AI, robotics, biotech, and web3, with check sizes typically aligned with early-stage funding needs. Their commitment includes building a supportive community for entrepreneurs through various service offerings.
Next Capital's notable investments include 元气森林 (Genki Forest), a health-focused beverage company; 硅基仿生 (Silicon Bionic), which develops blood glucose monitoring devices; and 熊猫速汇 (Panda Remit), a fintech platform for global remittances. Other portfolio companies include 士泽生物 (Shizai Biotechnology), 荷声科技 (HeSheng Technology), and 多抓鱼 (Duozhuayu).
Email your pitch deck to bp@jiachengcap.com for consideration.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.